Select Committee on Intergovernmental Organisations Minutes of Evidence


Memorandum submitted jointly by the Department of Health, Department for International Development and Foreign & Commonwealth Office

INTRODUCTION

  1.  The Government welcomes the Committee's decision to select this issue as the subject of its first inquiry and looks forward to assisting the Committee's considerations. This memorandum is submitted jointly by the UK government departments responsible for the government's contributions in this area. The Memorandum outlines the Government's overall approach to working through intergovernmental organisations on health and specifically on communicable diseases. The annex responds to the questions set out in the Committee's call for evidence.

  2.  The Government architecture for dealing with all the aspects of these particular diseases does not fall to any single Department or Agency. The answer to question 6 in the Annex does outlines the roles of most of the key Departments.

TACKLING INFECTIOUS DISEASE

  3.  Throughout the world, communicable diseases are a threat to economic growth and human development. Tackling communicable diseases is crucial for the UK's security and if it is to meet many of the Government's domestic and international Public Service Agreement targets.[1]

  4.  Over 50% of all child deaths are attributable to diarrhoea, pneumonia, malaria, measles and AIDS.[2] Most of these deaths are in developing countries. Without tackling them we will not meet the Millennium Development Goals (MDGs).

  5.  The World Health Organization (WHO) reported that in 2005 there were 8.8 million new cases of TB and 1.6 million deaths. Yet, if TB disease is detected early and fully treated, it quickly become non-infectious and is eventually cured. Early and complete treatment is also essential to ameliorate the increasing global problem of drug resistance.

  6.  HIV is one of the greatest threats to eradicating poverty, sustainable development and achieving the MDGs. In sub-Saharan Africa, it is the leading cause of death and the World Bank has predicted that, unless action is taken, parts of Africa will face "economic collapse".[3] Treatment programmes are increasingly being rolled out, but in the developing world (at the end of 2006, most recent figures) just over two million people in low and middle income countries were receiving therapy. This represents 28% of those in need of treatment. Europe is affected by HIV too, particularly in some of the new EU member states and neighbouring countries in Eastern Europe. In Western Europe, infection rates are continuing to rise, although deaths from AIDS have fallen.

  7.  But communicable diseases are also a threat to the UK. A Chief Medical Officer's report, Getting ahead of the Curve, was published in 2002.[4] It outlined the threat of infectious diseases to England and identified a strategy for how England would tackle communicable diseases more effectively. The report said that while major infectious diseases kill only a small number of people compared to the past, infection is still important: 40% of people consult a health professional each year because of infection.

  8.  Emerging diseases remain a constant threat to the UK and other countries. Since the 1970s, there have been at least 30 new or emerging infectious diseases. Most have not shown rapid global spread, but some have. Severe acute respiratory syndrome (SARS) was one example where there was rapid global spread. Between March and July 2003, there were 8,000 cases of SARS in 26 countries and 774 people died In Canada, SARS was estimated to have cost the economy C$1.5 billion in 2003 The global economic impact of SARS was estimated at US$30 billion.

  9.  During the four years 2003-07, avian influenza (H5N1) has infected over 350 people in 14 countries and over 217 have died.[5] This virus could mutate and cause a human pandemic. While there has not been a pandemic since 1968 another one is inevitable, whether or not it arises from H5N1. Estimates are that the next pandemic will kill between two million and 50 million people worldwide and between 50,000 and 750,000 in the UK.[6] Socioeconomic disruption will be massive.

  10.  The Office of Science and Innovation (OSI) 2006 report on the Foresight Project, Infectious Diseases: Preparing for the Future, comprehensively outlines the threat of infectious diseases today and in the future.[7] It considers the ways that we can respond by developing systems to detect, identify and monitor new and emerging infections.

  11.  Tackling communicable diseases requires a concerted effort from governments, non-governmental partners and multilateral agencies. When agencies work together they can achieve much. Immunisation programmes are a case in point. They have underpinned much of the gain made in childhood survival over the last few decades in developed and developing countries. Smallpox, which had previously affected 10 million people per year, claimed its last victim in 1978. We are now all working to ensure that polio becomes the second disease to be eradicated.

THE ROLE OF INTERGOVERNMENTAL ORGANISATIONS IN HEALTH

  12.  The Government attaches vital importance to the international architecture, including organisations such as the United Nations and the international financial institutions. As the Prime Minister said in his speech at the Lord Mayor's Banquet on 12 November, "To build not just security but environmental stewardship and prosperity free of global poverty, I want a G8 for the 21st century, a UN for the 21st century, and an IMF and World Bank fit for the 21st century". The Foreign Secretary has also stressed the crucial challenge of using the international system to create the necessary synergies for action. In his first speech in July he said that "The risk of financial crises, climate change, and health pandemics cannot be mitigated by individual countries; they require collective action on a global scale".

  13.  As the Foreign Secretary's speech indicated, there is increasing recognition that, with accelerating globalisation, health is an issue that needs to be addressed across national borders as well as across a wider range of government departments than those traditionally associated with health policy. In response to this the Government is currently developing a cross-government Global Health Strategy that identifies how the UK will engage on health internationally for the benefit of the UK population and UK health protection, and for the promotion of better health worldwide, including how the Government engages with international organisations to achieve this.[8]

  14.  Intergovernmental organisations, including the UN agencies, development banks, global funds and health partnerships, have a central role in health and specifically the control of the spread of communicable diseases. For example, the World Health Organisation (WHO) has a crucial role in disease surveillance and in providing high quality guidance to countries on acceptable standards of disease prevention and treatment. It also makes a major contribution through technical assistance to countries in boosting basic health services, monitoring health outcomes and accessing resources from global funds. The World Bank plays a complementary role in assisting the development of health systems to deliver the basic health services which help control communicable diseases. The World Bank and the regional development banks can ensure that health is prioritised in national development frameworks and budgets. They will not move away from disease-specific initiatives but complement health systems strengthening through broader financing for public services and longer-term budgetary support. Global health initiatives such as the Global Fund to fight AIDS, TB and Malaria (GFATM) and the Global Alliance for Vaccines and Immunisation (GAVI) also have a key role. It is estimated that the GFATM now provides 66% of all global TB and malaria funding, and about 22% of global funding for HIV/AIDS. It is estimated that GAVI has prevented 2.3 million premature deaths, and has provided 166 million additional vaccines. UNITAID (a new partnership) provides significant funding for medicines for AIDS, TB and Malaria, and negotiates significant price reductions and invests in "niche" or neglected products (eg paediatric formulations of antiretroviral therapy).

PROMOTING A COHERENT INTERNATIONAL RESPONSE

  15.  The Government works in close partnership with these organisations to promote global health and the achievement of the health-related Millennium Development Goals (MDGs) generally and specifically to combat communicable diseases. A key part of this is promoting effective operation and working together. There is considerable scope to improve the effectiveness and coherence of these and other intergovernmental organisations working on health and communicable diseases by strengthening the performance and accountability of individual institutions and encouraging more effective co-operation between agencies, and between the agencies and governments. The International Health Partnership launched in September 2007[9] is combining health system strengthening with improved alignment by donors and international health agencies including those with a disease-specific mandate.

  16.  The UK is committed to promoting a more coherent international response to health, based upon a sensible division of labour and joint accountability in supporting country plans and priorities. The current architecture is crowded and poorly coordinated. Within the diverse group of organisations there is no agreed vision or clarity over roles. This is particularly the case for WHO (WHO is either engaged in, or hosts, multiple partnerships) and the World Bank over assisting countries to develop national health systems. The International Health Partnership represents a UK response, which helps encourage a common framework for action on global health and a balance between disease specific (vertical) and health systems (horizontal) investment.

  17.  The Government considers that global health initiatives will also continue to play an important role but the transaction costs they impose on governments must fall and they must collaborate better with national processes in implementing countries. They should also support strengthening of health systems that deliver health services more broadly—for example, ensuring better integration of common interests, such as reproductive health and HIV and AIDS services. The GFATM is well placed to do this, and to support comprehensive approaches to AIDS, TB and malaria and underlying health services. GAVI, with long term and predictable financing provided through IFFIm—the International Finance Facility for Immunisation—can play a key role in helping countries put in place stronger systems for vaccine delivery as part of the overall effort to improve health services.

  18.  In the medium term, the Government believes the large number of existing initiatives should be rationalised through mergers. In the shorter term, the global funds, regional and international finance institutions and UN systems need to demonstrate much closer collaborative support of country health plans.

UN REFORM

  19.  The UK strongly supports the UN reform agenda for achieving greater coherence, effectiveness and efficiency of UN to deliver progress against the MDGs. DFID spends approximately $1 billion a year through the UN. It is important that these funds are given in a way that advances the UN reform agenda across the totality of the UN system.

  20.  This means making hard choices about funding the parts of the UN system that are reforming and performing well. While overall the UN makes a significant contribution to health, duplication, overlap and competition between agencies (WHO, UNICEF, UNFPA and UNAIDS) and numerous global health partnerships leads to inefficiencies.

  21.  At the global level, health funding to UN agencies is often fragmented and insufficient for the implementation of strategic plans. DFID seeks to provide, and encourage others to provide, central institutional support through core funding to UN institutions which demonstrate results, not earmarked funding to fight specific diseases. At a country level the UK supports the creation of "One UN teams" that will respond coherently to countries' developmental priorities. DFID favours funding joint programmes under unified UN country plans rather than standalone health initiatives of individual agencies.

January 2008



1   http://www.hm-treasury.gov.uk/pbr_csr/psa/pbr_csr07_psaindex.cfm Back

2   UK Chief Medical Adviser. Health is global: proposals for a UK Government-wide strategy. London: Department of Health, 2007 Back

3   Bell C, Devarajan S and Gersbach H (2003) The Long-run Economic Costs of AIDS: Theory and an Application to South Africa, World Bank, www1.worldbank.org/hiv_aids/docs/BeDeGe_BP_total2.pdf Back

4   Chief Medical Officer for England. Getting ahead of the curve. London: Department of Health, 2002 Back

5   http://www.who.int/csr/disease/avian_influenza/en/index.html Back

6   National Framework for responding to an influenza pandemic Back

7   Office for Science and Innovation. Infectious Diseases: Preparing for the Future The Foresight Project. Department of Trade and Industry. 2006 Back

8   The rationale for the Global Health Strategy is outlined in a report by the Chief Medical Officer for England-Health is Global: Proposal for a UK Government-Wide Strategy Back

9   http://www.dfid.gov.uk/news/files/pressreleases/ihp.asp Back


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008